Press Releases
CIT/ABC acquires assets of LAB Research Inc.
Applied Biology Company (ABC), the holding company of CIT Safety & Health Research Laboratories (CIT), a leading player among European preclinical CROs, announces today the purchase of substantially all of the assets of LAB Research Inc. (LAB Research), consisting...
Press Releases
AMRI Announces Development and Commercial Supply Agreement with Parnell Manufacturing
AMRI announced that it has entered into a development and long term exclusive commercial supply agreement with Parnell Manufacturing Pty Ltd (Parnell), an Australian company specializing in the research, development and manufacture of veterinary products. Under...
Press Releases
Lundbeck’s partner Mochida receives approval of Lexapro in Japan
H. Lundbeck A/S announced that our partner Mochida Pharmaceutical Co., Ltd. (Mochida) has obtained approval of Lexapro® 10 mg (escitalopram) from the Japanese Ministry of Health, Labour and Welfare (MHLW). Lundbeck has partnered...
Press Releases
Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851
Amgen and UCB announced positive top-line results from their Phase 2 clinical study comparing sclerostin-antibody AMG 785/CDP7851 to placebo in postmenopausal women with low bone mineral density (BMD) for the treatment of postmenopausal osteoporosis (PMO). This...
Press Releases
FDA Approves Roche’s HPV Test for Identifying Women at Highest Risk for Cervical Cancer
Roche announced that the US Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk for developing cervical cancer. This test will help physicians make early, more accurate decisions...
Press Releases
BioSante Pharmaceuticals Announces Pancreatic and Prostate Cancer Vaccine License
BioSante Pharmaceuticals, Inc. announced it has licensed its Pancreas Cancer Vaccine and Prostate Cancer Vaccine to Aduro BioTech, a clinical-stage immunotherapy company, solely for use in combination with Aduro's proprietary vaccine platform based on Listeria monocytogenes (Lm). ...
Press Releases
Trophos presents data at the American Academy of Neurology on SMA and MS
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today that Trophos has described the design of its pivotal clinical study of olesoxime...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read